O007 : All oral HCV therapy is safe and effective in patients with decompensated cirrhosis: Interim report from the HCV-target real world experience

Authors :: Paul Y. Kwo
Michael W. Fried
Michael P. Manns
Alexander Kuo
Rajender Reddy
Joy Peter
Monika Vainorius
Giuseppe Morelli
Hugo E. Vargas
Joseph K. Lim
Robert S. Brown
Mark S. Sulkowski
Thomas G. Stewart
L. Akuskevich
David R. Nelson
Joseph S. Galati
G.T. Everson
A. M. Di Bisceglie
Source :: Journal of Hepatology. 62:S193
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
medicine
Hcv therapy
In patient
Intensive care medicine
Decompensated cirrhosis
business
Interim report

Tools